Incannex Healthcare Inc. (NASDAQ: IXHL)
$2.57
+0.0200 ( +0.78% ) 28.1K
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Market Data
Open
$2.57
Previous close
$2.55
Volume
28.1K
Market cap
$44.81M
Day range
$2.39 - $2.67
52 week range
$0.80 - $12.68
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Nov 20, 2023 |
6-k | Quarterly Reports | 3 | Nov 17, 2023 |
6-k | Quarterly Reports | 30 | Nov 17, 2023 |
6-k | Quarterly Reports | 5 | Nov 16, 2023 |
6-k | Quarterly Reports | 5 | Nov 08, 2023 |
6-k | Quarterly Reports | 2 | Nov 07, 2023 |
20-f | Annual reports | 154 | Oct 31, 2023 |
6-k | Quarterly Reports | 4 | Oct 26, 2023 |
6-k | Quarterly Reports | 5 | Oct 19, 2023 |
6-k | Quarterly Reports | 11 | Oct 10, 2023 |